Respiree

Respiree is a health tech company based in Singapore, founded in 2019. It specializes in managing disease progression for cardio-pulmonary conditions through a patented wearable sensor and an AI-powered platform. The company focuses on remote patient monitoring, early deterioration detection, and decentralized clinical trials, aiming to improve patient outcomes for conditions like COPD and congestive heart failure.

Headquartered on Orchard Road, Respiree has expanded its operations to include a US headquarters in Houston and serves markets in Australia, Europe, and Asia-Pacific, with plans for further expansion. The company has received various regulatory approvals, including US FDA clearance and CE approval, and holds multiple certifications for quality and cybersecurity. Respiree has raised $11.6 million in Series A funding to enhance its AI tools and grow its commercial presence. Its product offerings include Respiree Care, a remote-care solution, and Respiree 1Bio, a platform for decentralized clinical trials.